Skoka Raises $21.5M, Submits 55 Products for FDA Review
The nicotine startup prepares for a 2027 U.S. retail launch following a major capital injection and federal regulatory filing.
Updated on Oct. 30, 2026 in Startups

Live Poll
Should the government allow the retail sale of new nicotine pouch brands?
Nicotine startup Skoka has raised $21.5 million in capital and submitted a bundled Premarket Tobacco Product Application to the FDA. The application includes 55 distinct products, setting the stage for a planned U.S. retail distribution launch in 2027.
Why it matters
The company is seeking regulatory clearance for a large, multi-variety product portfolio while targeting the adult nicotine consumer market. This move highlights the capital-intensive nature of navigating federal health compliance before reaching the consumer.
Skoka raised $21.5 million from investors, including professional athletes and executives, to fund the development of 55 products submitted for FDA review. The portfolio covers 11 varieties across five different strengths.
The players
Skoka
A startup founded in 2024 that is developing a range of nicotine products for the adult consumer market.
Dan Aziz
The founder of Skoka, which targets the adult nicotine consumer market.
Food and Drug Administration
The federal agency responsible for regulating tobacco and nicotine products through the Premarket Tobacco Product Application process.
The details
Skoka is utilizing a bundled Premarket Tobacco Product Application to seek authorization for its full lineup of 55 products in one regulatory motion. By securing this capital, the company is bridging the gap between product development and the formal federal review process required to sell nicotine products to adults 21 and older in the U.S. market.
Timeline
2024: Skoka was founded.
October 30, 2026: Skoka announced the funding round and the filing of its PMTA application.
2027: The company plans to begin retail distribution across the United States.
Market Landscape
The filing follows the standard FDA Premarket Tobacco Product Application requirements, which dictate the compliance pathway for all nicotine products. Skoka's bundled approach aims to secure authorization for its portfolio before its planned 2027 market entry.
Operators in the nicotine and retail space should monitor the FDA's decision on the bundled application as a benchmark for product portfolio scaling. Management teams should note the capital intensity required for federal compliance before achieving any retail footprint.
The takeaway
Navigating the Premarket Tobacco Product Application process remains the primary gatekeeper for new market entrants. Founders should track the timeline for this 55-product application as a case study for regulatory risk management in the nicotine sector.
Further reading
For more on how new ventures navigate regulatory hurdles, visit the Startups section.
Source note: This article includes information reported by Vcnewsdaily.
Live Poll
Should the government allow the retail sale of new nicotine pouch brands?




